Wei‐Jiunn Lee

1.0k citations
25 papers · 771 indexed · h-index 15
Topics
Renal and related cancers (4 papers)Renal cell carcinoma treatment (3 papers)Inflammation biomarkers and pathways (3 papers)
Partner nations
TaiwanUnited States

In The Last Decade

Wei‐Jiunn Lee

25 papers receiving 764 citations

Peers

Wei‐Jiunn Lee
Comparison fields: 5 of 89
  • Molecular Biology 457
  • Cancer Research 173
  • Oncology 127
  • Pharmacology 81
  • Pulmonary and Respiratory Medicine 77
Replace Deok‐Beom Jung with:
Deok‐Beom Jung South Korea
Weiwei Tao China
Ju‐Ha Kim South Korea
Wangbing Chen China
Pei-Fang Hung Taiwan
Sarah Fogarty United Kingdom
Seung‐Lark Hwang South Korea
Filiz Bakar‐Ates Türkiye
Maria Fedorova Russia
Gülperi Öktem Türkiye
Wei‐Jiunn Lee relative to Deok‐Beom Jung South Korea Deok‐Beom Jung's profile →
Citations per field
00.5×1.5×2.0×
Deok‐Beom Jung · 1×
Citations per year

Countries citing papers authored by Wei‐Jiunn Lee

Since Specialization
Citations

This map shows the geographic impact of Wei‐Jiunn Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Jiunn Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Jiunn Lee more than expected).

Fields of papers citing papers by Wei‐Jiunn Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Jiunn Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Jiunn Lee. The network helps show where Wei‐Jiunn Lee may publish in the future.

Co-authorship network of co-authors of Wei‐Jiunn Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Jiunn Lee. A scholar is included among the top collaborators of Wei‐Jiunn Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Jiunn Lee. Wei‐Jiunn Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 5
4 7
5 10
6 10
7 24
8 12
9 18
10 21
11 30
12 33
13 28
14 41
15 111
16 131
17 82
18 33
19 47
20 26

About Wei‐Jiunn Lee

Wei‐Jiunn Lee is a scholar working on Geriatrics and Gerontology, Cancer Research and Complementary and alternative medicine, having authored 25 papers that have together received 771 indexed citations. Recurring topics across this work include Renal and related cancers (4 papers), Renal cell carcinoma treatment (3 papers) and Inflammation biomarkers and pathways (3 papers). The work is most often cited by research in Cancer Research (173 citations), Endocrine and Autonomic Systems (73 citations) and Biochemistry (58 citations). Wei‐Jiunn Lee has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Ming‐Hsien Chien, Jyh‐Ming Chow, Michael Hsiao, Yi‐Chieh Yang, Liang‐Ming Lee, Shun‐Fa Yang, Yu‐Ching Wen, Tsui‐Hwa Tseng, Peng Tan and Yung‐Wei Lin. Their work appears in journals such as The EMBO Journal, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026